TCT 334: Technical Analysis and Procedural Outcomes of Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Interventions:Insights from an International Multicenter Registry

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Abiomed